[ad_1] Excited about the first FDA-approved therapeutic delivered into the #suprachoroidal space! https://t.co/L4NackGcXi [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Honored to be recognized as a Castle Connolly Top Doctor, by peer vote, for 2022, and for the past 10 years. https://t.… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @eurotimes: Ongoing clinical studies exploring subretinal and suprachoroidal administration are showing promising results in the treatme… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @eyetubenet: Want to Know More About the Future of Suprachoroidal Injections? Check out this CME series featuring a New Supplement & on-… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Dr Steven Yeh Discusses Xipere Delivery Mechanism and Benefits https://t.co/F1QDT92Tcm via @AJMC_Journal [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @fightblindness: Announced today, our own Dr. Ben Yerxa has been appointed to the Board of Directors at @clearsidebio, a #biopharmaceuti… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @RetinaToday: Despite its excellent safety profile, intravitreal delivery of certain meds poses inherent limitations. This has been addr… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.